IVD (In Vitro Diagnostic) Testing Market Report

Global IVD (In Vitro Diagnostic) Testing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：231
  • REPORT CODE：GMM767421
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • IVD (In Vitro Diagnostic) Testing market report explains the definition, types, applications, major countries, and major players of the IVD (In Vitro Diagnostic) Testing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • F Hoffmann-La Roche

    • Thermo Fisher Scientific

    • Siemens Healthineers

    • Danaher (Beckman Coulter Inc)

    • Abbott Laboratories

    By Type:

    • Point-of-Care Diagnostic

    • Immunochemistry Diagnostics

    • Clinical Chemistry Diagnostic

    • Molecular Diagnostics

    • Hematology Diagnostic Instruments

    • Microbiology Diagnostic

    • Hematology Diagnostic Instruments

    • Hemostasis Diagnostics

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global IVD (In Vitro Diagnostic) Testing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 IVD (In Vitro Diagnostic) Testing Outlook to 2028- Original Forecasts

    • 2.2 IVD (In Vitro Diagnostic) Testing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term IVD (In Vitro Diagnostic) Testing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global IVD (In Vitro Diagnostic) Testing Market- Recent Developments

    • 6.1 IVD (In Vitro Diagnostic) Testing Market News and Developments

    • 6.2 IVD (In Vitro Diagnostic) Testing Market Deals Landscape

    7 IVD (In Vitro Diagnostic) Testing Raw Materials and Cost Structure Analysis

    • 7.1 IVD (In Vitro Diagnostic) Testing Key Raw Materials

    • 7.2 IVD (In Vitro Diagnostic) Testing Price Trend of Key Raw Materials

    • 7.3 IVD (In Vitro Diagnostic) Testing Key Suppliers of Raw Materials

    • 7.4 IVD (In Vitro Diagnostic) Testing Market Concentration Rate of Raw Materials

    • 7.5 IVD (In Vitro Diagnostic) Testing Cost Structure Analysis

      • 7.5.1 IVD (In Vitro Diagnostic) Testing Raw Materials Analysis

      • 7.5.2 IVD (In Vitro Diagnostic) Testing Labor Cost Analysis

      • 7.5.3 IVD (In Vitro Diagnostic) Testing Manufacturing Expenses Analysis

    8 Global IVD (In Vitro Diagnostic) Testing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global IVD (In Vitro Diagnostic) Testing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global IVD (In Vitro Diagnostic) Testing Export by Region (Top 10 Countries) (2017-2028)

    9 Global IVD (In Vitro Diagnostic) Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Point-of-Care Diagnostic Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Immunochemistry Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Clinical Chemistry Diagnostic Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Hematology Diagnostic Instruments Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Microbiology Diagnostic Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Hematology Diagnostic Instruments Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Hemostasis Diagnostics Consumption and Growth Rate (2017-2022)

    • 9.2 Global IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise IVD (In Vitro Diagnostic) Testing Market Analysis and Outlook till 2022

    • 10.1 Global IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.2.2 Canada IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.2.3 Mexico IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.2 UK IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.3 Spain IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.4 Belgium IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.5 France IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.6 Italy IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.7 Denmark IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.8 Finland IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.9 Norway IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.10 Sweden IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.11 Poland IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.12 Russia IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.3.13 Turkey IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.2 Japan IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.3 India IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.4 South Korea IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.5 Pakistan IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.6 Bangladesh IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.7 Indonesia IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.8 Thailand IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.9 Singapore IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.10 Malaysia IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.11 Philippines IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.4.12 Vietnam IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.5.2 Colombia IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.5.3 Chile IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.5.4 Argentina IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.5.5 Venezuela IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.5.6 Peru IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.5.7 Puerto Rico IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.5.8 Ecuador IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.6.2 Kuwait IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.6.3 Oman IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.6.4 Qatar IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.7.2 South Africa IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.7.3 Egypt IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.7.4 Algeria IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

      • 10.8.2 New Zealand IVD (In Vitro Diagnostic) Testing Consumption (2017-2022)

    11 Global IVD (In Vitro Diagnostic) Testing Competitive Analysis

    • 11.1 F Hoffmann-La Roche

      • 11.1.1 F Hoffmann-La Roche Company Details

      • 11.1.2 F Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 F Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

      • 11.1.4 F Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Thermo Fisher Scientific

      • 11.2.1 Thermo Fisher Scientific Company Details

      • 11.2.2 Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

      • 11.2.4 Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Siemens Healthineers

      • 11.3.1 Siemens Healthineers Company Details

      • 11.3.2 Siemens Healthineers IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Siemens Healthineers IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

      • 11.3.4 Siemens Healthineers IVD (In Vitro Diagnostic) Testing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Danaher (Beckman Coulter Inc)

      • 11.4.1 Danaher (Beckman Coulter Inc) Company Details

      • 11.4.2 Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

      • 11.4.4 Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Abbott Laboratories

      • 11.5.1 Abbott Laboratories Company Details

      • 11.5.2 Abbott Laboratories IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Abbott Laboratories IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

      • 11.5.4 Abbott Laboratories IVD (In Vitro Diagnostic) Testing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    12 Global IVD (In Vitro Diagnostic) Testing Market Outlook by Types and Applications to 2028

    • 12.1 Global IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Point-of-Care Diagnostic Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Immunochemistry Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Clinical Chemistry Diagnostic Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Hematology Diagnostic Instruments Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Microbiology Diagnostic Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Hematology Diagnostic Instruments Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Hemostasis Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise IVD (In Vitro Diagnostic) Testing Market Analysis and Outlook to 2028

    • 13.1 Global IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.2.2 Canada IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.2 UK IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.3 Spain IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.5 France IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.6 Italy IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.8 Finland IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.9 Norway IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.11 Poland IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.12 Russia IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.2 Japan IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.3 India IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.5.3 Chile IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.5.6 Peru IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.6.3 Oman IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand IVD (In Vitro Diagnostic) Testing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of IVD (In Vitro Diagnostic) Testing

    • Figure of IVD (In Vitro Diagnostic) Testing Picture

    • Table Global IVD (In Vitro Diagnostic) Testing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global IVD (In Vitro Diagnostic) Testing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Point-of-Care Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Global Immunochemistry Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Chemistry Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Hematology Diagnostic Instruments Consumption and Growth Rate (2017-2022)

    • Figure Global Microbiology Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Global Hematology Diagnostic Instruments Consumption and Growth Rate (2017-2022)

    • Figure Global Hemostasis Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Table North America IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Figure United States IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Canada IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Mexico IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Table Europe IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Figure Germany IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure UK IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Spain IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Belgium IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure France IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Italy IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Denmark IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Finland IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Norway IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Sweden IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Poland IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Russia IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Turkey IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Table APAC IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Figure China IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure India IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Thailand IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Singapore IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Philippines IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Table South America IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Figure Brazil IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Colombia IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Chile IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Argentina IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Peru IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Table GCC IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Figure Bahrain IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Oman IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Qatar IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Table Africa IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Figure Nigeria IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure South Africa IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Egypt IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure Algeria IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Table Oceania IVD (In Vitro Diagnostic) Testing Consumption by Country (2017-2022)

    • Figure Australia IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand IVD (In Vitro Diagnostic) Testing Consumption and Growth Rate (2017-2022)

    • Table F Hoffmann-La Roche Company Details

    • Table F Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

    • Table F Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Product Portfolio

    • Table Thermo Fisher Scientific Company Details

    • Table Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

    • Table Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Product Portfolio

    • Table Siemens Healthineers Company Details

    • Table Siemens Healthineers IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthineers IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

    • Table Siemens Healthineers IVD (In Vitro Diagnostic) Testing Product Portfolio

    • Table Danaher (Beckman Coulter Inc) Company Details

    • Table Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

    • Table Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Product Portfolio

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories IVD (In Vitro Diagnostic) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories IVD (In Vitro Diagnostic) Testing Main Business and Markets Served

    • Table Abbott Laboratories IVD (In Vitro Diagnostic) Testing Product Portfolio

    • Figure Global Point-of-Care Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunochemistry Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Chemistry Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hematology Diagnostic Instruments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microbiology Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hematology Diagnostic Instruments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hemostasis Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Table North America IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Figure United States IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Figure Germany IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Figure China IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Figure Brazil IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania IVD (In Vitro Diagnostic) Testing Consumption Forecast by Country (2022-2028)

    • Figure Australia IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand IVD (In Vitro Diagnostic) Testing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US